Skip to main content
. 2021 Nov 16;8:693288. doi: 10.3389/fsurg.2021.693288

Table 3.

Clinical outcomes and complications.

Item Non-EAD EAD P-value
Intensive care unit length of stay (days) (mean) 5.28 (SD 4.40) 6.14 (SD 4.69) p = 0.007
Length of stay (days) (mean) 24.91 (SD 17.49) 29.52 (SD 22.85) p = 0.006
Clavien Dindo classification p = 0.087
      I 2% (9) 3% (6)
      II 15% (64) 17% (32)
      IIIa 12% (51) 10% (19)
      IIIb 20% (85) 16% (30)
      Iva 32% (137) 27% (51)
      IVb 5% (21) 8% (15)
      V 14% (60) 19% (36)
Arterial complications 9% (38) 12% (22) p = 0.271
Arterial dissection 2% (8) 2% (4) p = 0.827
Arterial thrombosis 2% (9) 4% (7) p = 0.242
Arterial stenosis 5% (21) 6% (11) p = 0.625
Portal vein stenosis 2% (7) 4% (7) p = 0.107
Venous thrombosis 3% (12) 4% (8) p = 0.351
Re-operation rate 33% (140) 50% (94) p < 0.001
Re-operation <30 days 27% (116) 42% (78) p < 0.001
Bleeding 13% (55) 23% (43) p = 0.002
Acute kidney failure 4% (15) 5% (9) p = 0.460
Bile duct leakage 14% (58) 22% (41) p = 0.010
Bile duct non-anastomotic stricture 11% (47) 16% (29) p = 0.122
Bile duct anastomotic stricture 28% (121) 26% (49) p = 0.575

Chi-square and Fisher's exact test for categorical variables; Mann-Whitney-U-Wilcoxon test for continuous variables.

EAD, Early allograft dysfunction.